Results 201 to 210 of about 2,340,402 (343)

Biotechnology and God [PDF]

Nature Medicine, 1995
openaire   +2 more sources

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin, Haocheng Yang, Feng Liu, Sihao Lin, Junru Hu, Jian Wang, Yulan Gou   +6 more
wiley   +1 more source

Correction: The biological relevance of potentially toxic metals in freshwater fish. [PDF]

Front Physiol
Kovacik A, Helczman M, Tomka M, Jambor T, Kovacikova E, Arvay J.   +5 more
europepmc   +1 more source

The patentability of biotechnology inventions [PDF]

, 2019
Benayad Djalila
openalex   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source

Primary bone marrow diffuse large B-cell lymphoma with secondary myelofibrosis: A case report. [PDF]

Oncol Lett
Yang J, Tu SK, Peng H, Peng YY, Li M, Song K.   +5 more
europepmc   +1 more source

Editorial Board: Biotechnology Journal 4/2011 [PDF]

, 2011

openalex   +1 more source

Higher Amyloid and Tau Burden Is Associated With Faster Decline on a Digital Cognitive Test

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective A 2‐min digital clock‐drawing test (DCTclock) captures more granular features of the clock‐drawing process than the pencil‐and‐paper clock‐drawing test, revealing more subtle deficits at the preclinical stage of Alzheimer's disease (AD). A previous cross‐sectional study demonstrated that worse DCTclock performance was associated with
Jessie Fanglu Fu, Talia Robinson, Marina Rodriguez Alonso, Adela Francis Malave, Roos J. Jutten, Michael J. Properzi, Brian C. Healy, Jackson C. Thompson, Grace Del Carmen Montenegro, Emma Thibault, Dana Penney, Randall Davis, Reisa A. Sperling, Kathryn V. Papp, Keith A. Johnson, Julie C. Price, Dorene M. Rentz   +16 more
wiley   +1 more source

Stem Cell R&D in Korea: Yesterday, Today, and Tomorrow - A Paradigm Shift from Therapeutics to Bio-Platforms. [PDF]

Int J Stem Cells
Kim MW, Do JT, Chang YS.
europepmc   +1 more source

Biotechnology in aquaculture health management - Winter school on recent advances in diagnosis and management of diseases in mariculture, 7th to 27th November 2002, Course Manual [PDF]

, 2002
K. M. Shankar
openalex